NSE: APOLLOHOSP | BSE: 508869

Strong Performer, Getting Expensive

Download real time

6937.00 3.50 (0.05%)

699 NSE+BSE Volume

NSE 19 Jun, 2025 9:07 AM (IST)

99,743.4

Market Cap

Market Runner Up

0.7

Beta 1Year

Very Low volatility

Apollo Hospitals Enterprise Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for APOLLOHOSP, BSE:508869 Apollo Hospitals Enterprise Ltd.

Apollo Hospitals Enterprise Ltd.

25 Jun 2021

6937.00

0.05%

Apollo Hospitals

Buy: Apollo Hospitals Enterpris...

Target

ICICI Securities Limited

While complete business normalisation in the healthcare segment is expected to be more pronounced from Q2FY22 onwards, Apollo's management has already charted a way to reduce costs in the short-term. We remain positive on the company as besides strong healthcare pedigree and asset base the company is on course to integrate all entities digitally to leverage its brand and physical presence. We maintain BUY with a revised TP of | 3870 (earlier | 3170) on SOTP basis by valuing healthcare business (existing hospitals & JV) at 20x FY23E EV/EBITDA, healthcare (new...

Apollo Hospitals Enterprise Ltd. is trading below its 30 day SMA of 6948.8

Apollo Hospitals Enterprise Ltd.

19 Apr 2021, 12:00AM

6937.00

0.05%

Pick of the Week - Apollo Hospitals Enterprise Ltd.

Buy: Apollo Hospitals Enterpris...

Edelweiss

Apollo Hospitals is widely recognised as the pioneer of private healthcare in India.

Apollo Hospitals Enterprise Ltd. is trading below its 30 day SMA of 6948.8

Apollo Hospitals Enterprise Ltd.

18 Feb 2021, 12:00AM

6937.00

0.05%

APOLLO HOSPITAL

Accumulate: Apollo Hospitals Enterpris...

Target

Geojit BNP Paribas

Rise in occupancy rate and patient footfalls Apollo Hospitals Enterprise Ltd operates the largest hospital network and pharmacy chain in India. The company owns around 71 Hospitals and...

Apollo Hospitals Enterprise Ltd. is trading below its 30 day SMA of 6948.8

Apollo Hospitals Enterprise Ltd.

14 Feb 2021

6937.00

0.05%

Apollo Hospitals

Buy: Apollo Hospitals Enterpris...

Recommendation Target

ICICI Securities Limited

While complete business normalisation in the healthcare segment is expected to be more pronounced from H1CY21 onwards, Apollo's management has already charted a way to reduce costs in the short-term. On the other hand, structural cost saving initiatives are also under way to reduce costs by 12-15% in the long-term. We remain positive on the company as besides strong healthcare pedigree and asset base the company owns one of the best pharmacy models in the world that provides an overall cushion in difficult times. We upgrade from HOLD to BUY at a...

Number of MF schemes increased from 253 to 305 in Mar 2025 qtr.

Apollo Hospitals Enterprise Ltd.

19 Nov 2020, 12:00AM

6937.00

0.05%

SAMVAT 2077

Buy: Apollo Hospitals Enterpris...

Recommendation Target

Karvy

On the technical front, APOLLOHOSP has been making higher highs and higher lows on the daily charts and is currently placed above the medium-term EMAs in the daily frame. In the recent past, after clocking a low of 1986 levels, the stock has witnessed a bounce and rallied to the current levels. At the current juncture, the stock has formed a base of around 1985 levels on the lower side and is all set to move higher.

Apollo Hospitals Enterprise Ltd. is trading above its 200 day SMA of 6886.0

Apollo Hospitals Enterprise Ltd.

13 Nov 2020

6937.00

0.05%

Apollo Hospitals

Hold: Apollo Hospitals Enterpris...

Recommendation Target

ICICI Securities Limited

Healthcare expansion moderates; focus on asset sweating Rapid expansion and maturity of older hospitals has kept overall growth tempo at 12-14% per annum. After a prolonged capex cycle, especially in FY14-18, Apollo is focusing on profitability and return ratios with capex moderation. This has reflected in a marked improvement in both EBITDA margins and RoCE. The new hospitals, ventures are turning profitable ahead of schedule on the back of a judicious case mix besides better occupancy and other matrix. We expect healthcare sales to grow at 9.5% FY20-23E...

Number of MF schemes increased from 253 to 305 in Mar 2025 qtr.

Apollo Hospitals Enterprise Ltd.

16 Sep 2020

6937.00

0.05%

Apollo Hospitals

Buy: Apollo Hospitals Enterpris...

Target

ICICI Securities Limited

Healthcare expansion moderates; focus on asset sweating Notwithstanding short-term fluctuations stemming from Covid, rapid expansion, maturity of older hospitals have kept overall growth tempo at 1214% per annum. After an intense capex cycle, especially in FY14-18, the company is focusing on profitability, return ratios with calculated capex moderation. This reflected in a marked improvement in both EBITDA margins, RoCE. The new hospitals and ventures are turning profitable ahead of schedule on the back of a judicious case mix besides better occupancy and other matrix. We expect healthcare sales to grow at ~8% CAGR in FY2022E to | 7544 crore mainly due to growth at new hospitals, AHLL....

Apollo Hospitals Enterprise Ltd. is trading below its 30 day SMA of 6948.8

Apollo Hospitals Enterprise Ltd.

28 Jun 2020

6937.00

0.05%

Apollo Hospital

Sell: Apollo Hospitals Enterpris...

Yes Securities

Ascribe 9x EV/EBIDTA to FY22 EBIDTA and 1x EV/sales eachtopharmacyandAHLLbusinesses;significantlybelow consensusonvaluationgiventhesubparoperatingmetrics...

Apollo Hospitals Enterprise Ltd. is trading below its 30 day SMA of 6948.8

Apollo Hospitals Enterprise Ltd.

03 Apr 2020

6937.00

0.05%

Hospital Sector Report

Buy: Apollo Hospitals Enterpris...

Target

ICICI Securities Limited

The impact of Covid-19 outbreak has taken a toll on hospital stocks most of which have corrected anywhere between 20% and 50% in the last month. We spoke with a few of them to assess the impact and way forward. Large players like Apollo Hospitals have seen a significant drop in occupancy levels to 40% from 69% amid restrictions on people movement (~50% patient volume are travelling patients) and postponement of elective procedures. Fortis has also started seeing a decline in number of elective surgeries resulting in a sharp fall of ~65%, 40% in OPD, IPD volumes,...

Number of FII/FPI investors increased from 1501 to 1548 in Mar 2025 qtr.

Is Apollo Hospitals Enterprise Ltd. worth buying?

224 Votes:

Buy 70.98%

Sell 20.09%

Hold 8.93%

RESEARCH REPORTS

Accumulate SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf